Horan Capital Advisors’s Medtronic MDT Stock Holding History

Horan Capital Advisors’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-74	Closed	-$8K	–	199
2020 Q3	$8K	Buy	+74	New	+$7.43K	﹤0.01%	256

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Horan Capital Advisors's MDT Position: Q4 2020 in Review

Horan Capital Advisors sold out of Medtronic (MDT) in Q4 2020, closing a stake of 74 shares — an estimated $8K sold.

Horan Capital Advisors first reported a position in MDT in Q3 2020 and held it in 1 quarter. The position peaked at $8K in Q3 2020. 1,957 funds tracked by Wall St. Rank hold MDT as of Q4 2020.

Horan Capital Advisors reported no remaining Medtronic position as of Q4 2020 after selling out during the quarter.
Horan Capital Advisors sold 74 Medtronic shares in Q4 2020, an estimated $8K.
Horan Capital Advisors first reported a position in Medtronic in Q3 2020 and held it in 1 quarter.
Horan Capital Advisors's Medtronic position peaked at $8K in Q3 2020.
1,957 funds tracked by Wall St. Rank held Medtronic as of Q4 2020.

Based on Horan Capital Advisors's 13F filing for Q4 2020, filed 2 Feb 2021.